A phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens.
E. P. Hui
No relevant relationships to disclose
G. S. Taylor
No relevant relationships to disclose
B. Ma
No relevant relationships to disclose
S. L. Chan
No relevant relationships to disclose
R. Ho
No relevant relationships to disclose
W. Wong
No relevant relationships to disclose
H. Jia
No relevant relationships to disclose
C. Edwards
No relevant relationships to disclose
A. B. Rickinson
No relevant relationships to disclose
A. T. C. Chan
No relevant relationships to disclose
N. M. Steven
No relevant relationships to disclose